These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 375088

  • 21. A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy.
    Niiranen A, Mattson K.
    Am J Clin Oncol; 1985 Aug; 8(4):336-40. PubMed ID: 3002167
    [Abstract] [Full Text] [Related]

  • 22. Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.
    Hesketh PJ, Gandara DR, Hesketh AM, Edelman M, Webber LM, McManus M, Hainsworth JD.
    Cancer J Sci Am; 1997 Aug; 3(3):180-3. PubMed ID: 9161784
    [Abstract] [Full Text] [Related]

  • 23. A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
    Cunningham D, Bradley CJ, Forrest GJ, Hutcheon AW, Adams L, Sneddon M, Harding M, Kerr DJ, Soukop M, Kaye SB.
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):685-9. PubMed ID: 2838294
    [Abstract] [Full Text] [Related]

  • 24. Antiemetic efficacy of prochlorperazine, haloperidol, and droperidol in cisplatin-induced emesis.
    Owens NJ, Schauer AR, Nightingale CH, Golub GR, Martin RS, Williams HM, Schauer PK.
    Clin Pharm; 1984 Apr; 3(2):167-70. PubMed ID: 6373102
    [Abstract] [Full Text] [Related]

  • 25. Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
    Ahmedzai S, Carlyle DL, Calder IT, Moran F.
    Br J Cancer; 1983 Nov; 48(5):657-63. PubMed ID: 6315040
    [Abstract] [Full Text] [Related]

  • 26. Antiemetics for patients treated with antitumor chemotherapy.
    Williams CJ, Bolton A, de Pemberton R, Whitehouse JM.
    Cancer Clin Trials; 1980 Nov; 3(4):363-7. PubMed ID: 6253100
    [Abstract] [Full Text] [Related]

  • 27. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG.
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [Abstract] [Full Text] [Related]

  • 28. Effects of nabilone, a synthetic cannabinoid, on postoperative pain.
    Beaulieu P.
    Can J Anaesth; 2006 Aug; 53(8):769-75. PubMed ID: 16873343
    [Abstract] [Full Text] [Related]

  • 29. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial.
    Ware MA, Fitzcharles MA, Joseph L, Shir Y.
    Anesth Analg; 2010 Feb 01; 110(2):604-10. PubMed ID: 20007734
    [Abstract] [Full Text] [Related]

  • 30. Nabilone: an alternative antiemetic for cancer chemotherapy.
    Dalzell AM, Bartlett H, Lilleyman JS.
    Arch Dis Child; 1986 May 01; 61(5):502-5. PubMed ID: 3013104
    [Abstract] [Full Text] [Related]

  • 31. Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.
    Berlach DM, Shir Y, Ware MA.
    Pain Med; 2006 May 01; 7(1):25-9. PubMed ID: 16533193
    [Abstract] [Full Text] [Related]

  • 32. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
    Drug Ther Bull; 1984 Feb 10; 22(3):9-11. PubMed ID: 6321126
    [No Abstract] [Full Text] [Related]

  • 33. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R, Herrstedt J, Rapoport B, Carides AD, Guoguang-Ma J, Elmer M, Schmidt C, Evans JK, Horgan KJ.
    Eur J Cancer; 2004 Feb 10; 40(3):403-10. PubMed ID: 14746859
    [Abstract] [Full Text] [Related]

  • 34. Nabilone as an antiemetic.
    Fox FJ.
    N Engl J Med; 1979 Sep 27; 301(13):728. PubMed ID: 481477
    [No Abstract] [Full Text] [Related]

  • 35. A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.
    Johansson R, Kilkku P, Groenroos M.
    Cancer Treat Rev; 1982 Dec 27; 9 Suppl B():25-33. PubMed ID: 6299551
    [No Abstract] [Full Text] [Related]

  • 36. Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.
    Orr LE, McKernan JF, Bloome B.
    Arch Intern Med; 1980 Nov 27; 140(11):1431-3. PubMed ID: 6254456
    [Abstract] [Full Text] [Related]

  • 37. [A study on the antiemetic effect and extrapyramidal symptoms of prochlorperazine versus perospirone for the control of nausea and vomiting due to opioid introduction].
    Yomiya K, Takei D, Kurosawa H, Kono B.
    Gan To Kagaku Ryoho; 2013 Aug 27; 40(8):1037-41. PubMed ID: 23986047
    [Abstract] [Full Text] [Related]

  • 38. Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy.
    Einhorn L.
    Cancer Treat Rev; 1982 Dec 27; 9 Suppl B():55-61. PubMed ID: 6299557
    [No Abstract] [Full Text] [Related]

  • 39. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
    Davis MP.
    Expert Opin Investig Drugs; 2008 Jan 27; 17(1):85-95. PubMed ID: 18095921
    [Abstract] [Full Text] [Related]

  • 40. Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study.
    Frank B, Serpell MG, Hughes J, Matthews JN, Kapur D.
    BMJ; 2008 Jan 26; 336(7637):199-201. PubMed ID: 18182416
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.